Publikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (7)

2024

  1. 18F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study

    Expert Review of Hematology, Vol. 17, Núm. 1-3, pp. 95-100

2023

  1. Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis

    Leukemia, Vol. 37, Núm. 7, pp. 1511-1520

  2. One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

    Blood Cancer Journal, Vol. 13, Núm. 1

  3. Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula

    Vox Sanguinis, Vol. 118, Núm. 4, pp. 288-295

2022

  1. Comparison Between Standard and High Dose of G-CSF for Mobilization of Hematopoietic Progenitors Cells in Patients and Healthy Donors

    Transfusion Medicine Reviews, Vol. 36, Núm. 3, pp. 159-163

  2. Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 11, pp. 1196-1205

2019

  1. Posaconazole salvage therapy: The Posifi study

    Mycoses, Vol. 62, Núm. 6, pp. 526-533